Name: Latest research reports of Alembic Pharmaceuticals Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alembic Pharmaceuticals Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Slowing Down Stock

839.4500 -12.75 (-1.50%)

NSE Dec 29, 2025 11:48 AM

25.31% Fall from 52W High

Volume: 13,497

Alembic Pharmaceuticals Ltd.

09 May 2024

839.45

-1.50%

Alembic Pharma (HOLD): Strong margins; positives priced in

Hold: Alembic Pharmaceuticals Ltd.

BOB Capital Markets Ltd.

ALPM reported strong margin gains in Q4 on account of better utilisation of new facilities and traction in the US business

Alembic Pharmaceutic.. has an average target of 1028.50 from 4 brokers.